G01N 2333/972
Plasminogen activators
G01N2333/972 (Plasminogen activators) appears on 170 US grants and 79 published applications in this corpus.
Search patents in G01N- Granted patents
- 170
- Published applications
- 79
- Assignees
- 88
- Inventors
- 277
- Latest grant
- 2 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 8 | 0 |
| 1993 | 5 | 0 |
| 1994 | 5 | 0 |
| 1995 | 8 | 0 |
| 1996 | 10 | 0 |
| 1997 | 22 | 0 |
| 1998 | 31 | 0 |
| 1999 | 9 | 0 |
| 2000 | 11 | 0 |
| 2001 | 12 | 0 |
| 2002 | 6 | 5 |
| 2003 | 3 | 17 |
| 2004 | 5 | 8 |
| 2005 | 2 | 6 |
| 2006 | 2 | 4 |
| 2007 | 1 | 1 |
| 2008 | 4 | 4 |
| 2009 | 1 | 4 |
| 2010 | 2 | 4 |
| 2011 | 1 | 2 |
| 2012 | 1 | 2 |
| 2013 | 0 | 2 |
| 2014 | 0 | 3 |
| 2015 | 0 | 1 |
| 2016 | 0 | 4 |
| 2017 | 1 | 2 |
| 2018 | 2 | 2 |
| 2019 | 2 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 2 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 3 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Method and composition for detection of proteolytic products and diagnosis of malignant neoplastic disease2 Jul 2024US 12,025,616 B2Evgeny Iosifovich Goufman
- Cardiotonic steroid antagonists and related methods22 Sep 2020US 10,781,431 B2Marshall University Research Corporation
- Method of detection of proteolysis products in plasma and a diagnostic system for its application15 Oct 2019US 10,444,236 B2
- Specific peptide binders to proteins identified via systematic discovery, maturation and extension process27 Aug 2019US 10,393,751 B2Roche Sequencing Solutions, Inc.
- Biomarkers useful in liver fibrosis diagnosis29 May 2018US 9,983,216 B2Industrial Technology Research Institute
- Novel Treatment of Diabetes and Kidney Disease by Inhibition of D2D3 a Proteolytic UPAR25 Sep 2025US 2025/0296999 A1Massachusetts General Hospital
- Protein biomarkers of inflammatory activity in multiple sclerosis12 Jun 2025US 2025/0189541 A1Oklahoma Medical Research Foundation
- Development of novel upar single-domain antibody6 Mar 2025US 2025/0074997 A1Persongen Biotherapeutics (Suzhou) Co., Ltd.
- Reporter labeled annular clot system for diagnosis and research10 Oct 2024US 2024/0337669 A1Indiana University Research and Technology Corporation
- Sars-cov-2 infection risk assessment method27 Jul 2023US 2023/0236196 A1Copenhagen University Hospital Amager and Hvidovre
Most cited
By later US patents
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997
- High-affinity nucleic acid ligands that discriminate between theophylline and caffeine277US 5,580,737 ANeXstar Pharmaceuticals, Inc. · 1996
- Systematic evolution of ligands by exponential enrichment: blended SELEX233US 5,683,867 ANeXstar Pharmaceuticals, Inc. · 1997